Global /United Kingdom /Healthcare /Medical Care Facilities /CIZ

Cizzle Biotechnology Holdings Plc

CIZ

• LSE: CIZ • Delayed

3GBX 11%

0.0354 USD

As of 8 June 2026, Cizzle Biotechnology Holdings Plc has a market cap of $12.74M USD, ranking #39946 globally and #899 in the United Kingdom. It ranks #3562 in the Healthcare sector, and #425 in the Medical Care Facilities industry.

Global Rank

39946

Country Rank

899

Sector Rank

3562

Industry Rank

425

Key Stats

Market Cap

$12.74MUSD

9.51M GBP

Enterprise Value

$12.65MUSD

9.48M GBP

Net Income (TTM)

-$1.5MUSD

-1.12M GBP

PB Ratio

-34.5

Company Profile

Country (HQ)

United Kingdom

Sector

Healthcare

Industry

Medical Care Facilities

Employees

Website

cizzlebiotechnology.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
11%	14%	6.7%	66%	66%	55%	60%	-27%	-55%

News

Markets

Exchange	Ticker	Price	Quotes
London Stock Exchange (LSE / LON) MIC: XLON PRIMARY	CIZ Cizzle Biotechnology Holdings PLC ISIN: GB00BNG2VN02 Shares Out.: Shares Outstanding: 424.963M¹ Shares Float: 380.8M² TV: TradingView: LSE: CIZ SA: Stock Analysis: LON: CIZ YF: Yahoo Finance: CIZ.L GF: Google Finance: LON: CIZ BA: Barron's: CIZ MS: Morningstar: XLON: CIZ	3 GBX	TV: TradingView: LSE: CIZ SA: Stock Analysis: LON: CIZ YF: Yahoo Finance: CIZ.L GF: Google Finance: LON: CIZ BA: Barron's: CIZ MS: Morningstar: XLON: CIZ
Frankfurt Stock Exchange (FRA) MIC: XFRA	E7F0 Cizzle Biotechnology Holdings PLC ISIN: GB00BNG2VN02 TV: TradingView: FWB: E7F0 SA: Stock Analysis: FRA: E7F0 YF: Yahoo Finance: E7F0.F GF: Google Finance: FRA: E7F0 BA: Barron's: E7F0 MS: Morningstar: XFRA: E7F0	0.0275 EUR	TV: TradingView: FWB: E7F0 SA: Stock Analysis: FRA: E7F0 YF: Yahoo Finance: E7F0.F GF: Google Finance: FRA: E7F0 BA: Barron's: E7F0 MS: Morningstar: XFRA: E7F0

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Cizzle Biotechnology Holdings Plc

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, operates as a cancer diagnostics company in the United Kingdom. It develops a non-invasive blood test for early lung cancer detection using CIZ1B biomarker technology. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.

Similar Companies

Industry: Medical Care Facilities (United Kingdom)

Name	Market Cap (USD) diff.	PE	Country
CVS Group plc LSE: CVSG	$1.09B 816.62M GBP 8K%	50.8	United Kingdom
Spire Healthcare Group plc LSE: SPI	$861.49M 643.36M GBP 7K%	40.2	United Kingdom
NIOX Group Plc LSE: NIOX	$380.56M 284.2M GBP 3K%	41.2	United Kingdom
Kooth plc LSE: KOO	$63.87M 47.7M GBP 401%	18.8	United Kingdom
EDX Medical Group PLC LSE: EDX	$59.28M 44.27M GBP 365%	-	United Kingdom
One Health Group Plc LSE: OHGR	$46.58M 34.79M GBP 266%	-	United Kingdom

Industry: Medical Care Facilities (Global)

Name	Market Cap (USD) diff.	PE	Country
International Holding Company PJSC ADX: IHC	$232.22B 852.82B AED 2M%	44.1	United Arab Emirates
HCA Healthcare, Inc. NYSE: HCA	$96.73B 759K%	14.9	United States
Fresenius SE & Co. KGaA XETRA: FRE	$26.47B 22.97B EUR 208K%	15.0	Germany
Koninklijke Philips N.V. AMS: PHIA	$25.37B 22.02B EUR 199K%	24.9	Netherlands
Dr. Sulaiman Al Habib Medical Services Group Co. TADAWUL: 4013	$22.46B 84.42B SAR 176K%	35.2	Saudi Arabia
Labcorp Holdings Inc. NYSE: LH	$21.13B 166K%	24.6	United States

chevron_leftBack